1. WHO (2010). Tuberculosis, fact sheet NO. 104.
2. FMOH (2005). FMOH.Teberculosis, Leprosy and TB/HIV prevention and control programme. Third ed. Addis Ababa
3. WHO (2010). Treatment of tuberculosis: guidelines 4th ed.
4. WHO (2008). Global Tuberculosis Control -Surveillance, Planning, Financing 2008. 2008; Available from:.
5. WHO (2011). Global tuberculosis control report of 2011.
6. WHO (2010). 2010 Global Tuberculosis Control. Global Tuberculosis Control Geneva World Health Organization
7. UN (2010). The Millennium Development Goals Report.
8. WHO (2009). Global Tuberculosis Control. A short update to the 2009 report.
9. FMOH (2010). health and health related indicator. Addis Ababa Ethiopian federal ministry of health
10. USAID (2009). Ethiopian Tuberculosis Profile 2009. Ethiopian Tuberculosis Profile
11. (2007). Summary and Statistical Report of the 2007. Summary and Statistical Report of the
12. M. Muñoz-Sellart,L. Cuevas,M. Tumato Merid Y, A.Yassin M. Factors associated with poor tuberculosis treatment outcome in the Southern Region of Ethiopia. The International Journal of Tuberculosis and Lung Disease, 14(8), 973-979.
13. Gebretsadik Berhe,Fikre Enquselassie,Abraham Aseffa (2012). Gebretsadik Berhe, Fikre Enquselassie and Abraham Aseffa .: Treatment outcome of smear-positive pulmonary tuberculosis patients in Tigray Region, Northern Ethiopia. BMC Public Health, 12(1), 537.
14. Selamawit Hirpa,Girmay Medhin,Belaineh Girma,Muluken Melese,Alemayehu Mekonen,Pedro Suarez,Gobena Ameni (2013). Selamawit Hirpa, Girmay Medhin, Belaineh Girma, Muluken Melese, Alemayehu Mekonen, Pedro Suarez and Gobena Ameni : Determinants of multidrug-resistant tuberculosis in patients who underwent first-line treatment in Addis Ababa: a case control study. BMC Public Health, 13, 782.
15. Daniel OJ,Oladapo OT,Alausa OK (2006). Default from tuberculosis treatment programme in Sagamu, Nigeria. Niger J Med, 15, 63-67.
16. Andrews JR,Shah NS,Weissman D,Moll AP,Friedland G (2010). Predictors of multidrug- and extensively drug-resistant Tuberculosis in a high HIV Prevalence community. PLoS One, 5(12), e15735.
17. M. Gelaw,T. Genebo,A. Dejene,E. Lemma,G. Eyob (2001). Attitude and social consequences of tuberculosis in Addis Ababa, Ethiopia. East Afr Med J, 78, 382-388.
18. Awofeso N (2008). Anti-tuberculosis medication side-effects constitute major factor for poor adherence to tuberculosis treatment. Bull World Health Organ, 86, 161-240.
19. S. Anunnatsiri,P. Chetchotisakd,C. Wanke (2005). Factors associated with treatment outcomes in pulmonary tuberculosis in northeastern Thailand. Southeast Asian J Trop Med Public Health, 36(2), 324-330.
20. A. Faustini,A. Hall,C. Perucci (2006). Risk factors for multidrug resistant tuberculosis in Europe: a systematic review. Thorax, 61, 158-163.
21. (2008). Rate and amplification of drug resistance among previously-treated patients with tuberculosis in Kampala, Uganda. Clin Infect Dis, 47, 1126-1134.
22. S. Akksilp,W. Wattanaamornkiat,W. Kittikraisak,S. Nateniyom,S. Rienthong,C. Sirinak,K. Ngamlert,W. Mankatittham,W. Sattayawuthipong,S. Sumnapun,N. Yamada,P. Monkongdee,A. Anuwatnonthakate,C. Burapat,C. Wells,J. Tappero,J. Varma (2009). Multidrug-resistant TB and HIV in Thailand: overlapping, but not independently associated, risk factors. Southeast Asian J Trop Med Public Health, 40, 1000-1014.
23. Corbett E,Watt C,Walker N (2003). The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med, 163, 1009.
24. Alcorn K (2007). HIV a major risk factor for MDR TB in Ukraine. AIDS map HIV & AIDS news
